hotspot -WSS

hotspot

author：Wikipedia 2025-09-02 22:07:26 - browse：57

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

focus

WSS

How redistricting in 6 states could affect who controls Congress

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Why Titanic fascinates society, still drawing tours to the wreckage

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Readout LOUD: Venture capital, Gilead, and more M&A

focus

hotspot

hotspot

Sports medicine is finally prioritizing gender equality

Problems with a popular proposal to regulate AI in health care

Drug repurposing or repositioning? The language matters

UPS workers' union leader explains what's at stake as strike edges closer

Moonlake's readout produced a cash windfall. Risks remain

Surgery pushed Ben Carson to fame

Medical leaders decry Supreme Court decision on affirmative action

Bernie brings in new pharma CEOs to talk drug prices

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Drinking water from half of US faucets contains PFAS: Study

leisure time

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Unique patient identifier: Experts argue the benefits, pitfalls

Why Novartis is going to walk from its acquisition of MorphoSys

Rare Northern Lights show in US this week: Where and how to see it

A single Democrat is willing to weaken Medicare negotiation power

Texas Medical Board asked to define abortion emergency exception

focus

explore

entertainment

hotspot